“Qualcomm announces strategic collaboration with Novartis”

January 12, 2015 | Reply More

“SAN DIEGO, Jan. 5, 2015 /PRNewswire/ – Qualcomm Incorporated (NASDAQ: QCOM) today announced that its subsidiary, Qualcomm Life, Inc., has been selected by Novartis, a global pharmaceutical leader, as a global digital health collaborator for its Trials of The Future program. Qualcomm Life’s 2net™ Platform will serve as a global connectivity platform for collecting and aggregating medical device data during clinical trials to improve the convenience and speed of capturing study participant data and test results to ultimately gain more trial efficiencies and connected experiences for participants.”

Read the full announcement here.

Category: Archives, In The News, Industry News, Member News, News

Leave a Reply